Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial
- PMID: 22946117
- DOI: 10.1212/01.wnl.0000419501.12719.38
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial
Comment on
-
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.Neurology. 2012 Apr 3;78(14):1069-78. doi: 10.1212/WNL.0b013e31824e8ee7. Epub 2012 Mar 21. Neurology. 2012. PMID: 22442431 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources